Skip navigation

Member Profile

Yogesh Sanghvi

Yogesh Sanghvi

Member

Screen Namerasayan03Activities3
Member SinceSep 22, 2014CoLab Points (actual)
0
CountryUnited StatesCoLab Points (max. potential)
0

Yogesh S. Sanghvi Founder and President, Rasayan Inc. (www.rasayan.us) In 1981, Dr. Sanghvi received his Ph.D. in organic chemistry from National Chemical Laboratory (Pune, India), where he worked on the synthesis of natural products. From 1982 – 1985, his post-doctoral research on the synthesis of modified nucleosides was carried out at University of London with Professor C.B. Reese. In 1986, he joined the Nucleic Acids Research Institute at ICN Pharmaceuticals, California. At ICN, he was involved in the design, synthesis and screening of novel nucleosides and nucleotides as antiviral and antitumor agents. From 1989 – 2003, he worked at Isis Pharmaceuticals, California. In 2003, he founded Rasayan Inc., a company focused on the consulting, outsourcing services and supply of products related to nucleic acid field. Rasayan is engaged in the strategic planning, securing raw materials for manufacture of oligonucleotide-based drugs on large-scale, experimental design, optimization of synthesis and purification protocols on lab scale to kilo scale, including process chemistry. His specific interests include design, synthesis, chemistry and biochemistry of novel carbohydrates, nucleosides, nucleotides, and oligonucleotides for their application in therapeutics, combinatorial chemistry and medical diagnostic research. Dr. Sanghvi has over 150 scientific publications in leading journals, including several book chapters and has more than 30 patents.

Proposals

Yogesh has not yet contributed to any Proposals.

Proposal Links

There are no Proposal linking to this member's Proposal yet.

Supporting

Yogesh has not yet supported any Proposal.

Activities

Yogesh Sanghvi updated a proposal Utilizing Molecularly Imprinted Technology to Selectively Filter PollutantsSep 22, 2014
Yogesh Sanghvi joined the Climate CoLab communitySep 22, 2014
SEE ALL